Jyong Biotech Ltd. Ordinary Shares enterprise value

The Enterprise Value as of November 2026 (TTM) for Jyong Biotech Ltd. Ordinary Shares (MENS) is 158.78M

According to Jyong Biotech Ltd. Ordinary Shares’s latest financial reports and current stock price. The company's current Enterprise Value is 158.78M. This represents a change of -37.22% compared to the average of 252.92M of the last 4 quarters.

Jyong Biotech Ltd. Ordinary Shares (MENS) Historical Enterprise Value (quarterly & annually)

How has MENS Enterprise Value performed in the past?

The mean historical Enterprise Value of Jyong Biotech Ltd. Ordinary Shares over the last ten years is 695.54M. The current 158.78M Enterprise Value has changed -77.17% with respect to the historical average. Over the past ten years (40 quarters), MENS's Enterprise Value was at its highest in in the June 2025 quarter at 645.00M. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.

Jyong Biotech Ltd. Ordinary Shares (MENS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Jyong Biotech Ltd. Ordinary Shares Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jyong Biotech Ltd. Ordinary Shares (MENS) Average Enterprise Value

How has MENS Enterprise Value performed in the past?

The current Enterprise Value of Jyong Biotech Ltd. Ordinary Shares (MENS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Jyong Biotech Ltd. Ordinary Shares (MENS) Enterprise Value vs. Peers

How is MENS’s Enterprise Value compared to its peers?

Jyong Biotech Ltd. Ordinary Shares’s Enterprise Value is less than Ultragenyx Pharmaceutical Inc. (2.65B), less than CG Oncology Inc. (5.43B), less than Centessa Pharmaceuticals plc (6.21B), less than Xenon Pharmaceuticals Inc. (3.52B), less than Celcuity Inc. (3.81B), less than Ascentage Pharma Group International (8.69B), less than Apogee Therapeutics, Inc. (8.30B), less than Legend Biotech Corporation (3.55B), less than Travere Therapeutics, Inc. (5.14B), less than Dyne Therapeutics, Inc. (2.47B),

Build a custom stock screener for Jyong Biotech Ltd. Ordinary Shares (MENS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jyong Biotech Ltd. Ordinary Shares using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jyong Biotech Ltd. Ordinary Shares (MENS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jyong Biotech Ltd. Ordinary Shares or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.